DiscoverStartupsIntellia Therapeutics
Intellia Therapeutics company logo
TREATING GENETIC DISEASE201-500 Employees
  • B2C
  • Public Stage
    Publicly traded company
  • 4.1
    Work / Life Balance
    Employees rate Intellia Therapeutics 4.1/5 on Glassdoor for work / life balance
Website
Location
Company size
201-500 people
Total raised
$85M
Markets
BiotechnologyHealthcareMedicalGenetic Testing
View 0 jobs

Intellia Therapeutics careers

TREATING GENETIC DISEASE
At intellia, we are building a full-spectrum, product-driven biotechnology company focused on developing and commercializing potentially curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. our approach to advancing the broad potential of genome editing includes our plans to enhance our crispr system. on the in vivo side, our systemic lipid nanoparticle or lnp-based delivery system, has the potential to unlock treatment of genetic diseases to both selectively knock out disease-causing genes and introduce targeted insertion of a functional gene.

we are also focused on engineering t cell therapies to preserve normal cell physiology. ​our approach is designed to improve safety and efficacy by engineering cell therapies​ that are more precise, potent and persistent.
Jobs

Intellia Therapeutics hasn't added any jobs yet

Get notified when Intellia Therapeutics posts new jobs.

See similar jobs
Intellia Therapeutics
Avatar for Intellia Therapeutics
Total raised

$85M

Funded over

2 rounds

Latest round

Series B (Sep 2015)

Fsa limits 2020 (per year)

401(k) limits 2020 (per year)

Employee stock purchase plan (espp)

Transportation limits 2020 (per month

Tuition reimbursement

Other Similar Companies Hiring
SugarCRM company logo
SugarCRMRomania • 1 week ago
Tamr company logo
TamrCambridge • 2 weeks ago
Wistia company logo
WistiaCambridge • 3 weeks ago
Quartzy company logo
QuartzyHouston • 3 weeks ago
Penumbra company logo
PenumbraBerlin • 3 weeks ago